Genomic polymorphism of human papillomavirus type 52 predisposes toward persistent infection in sexually active women

被引:38
作者
Aho, J
Hankins, C
Tremblay, C
Forest, P
Pourreaux, K
Rouah, F
Coutlée, F
机构
[1] Ctr Hosp Univ Montreal, Ctr Rech, Mol Virol Lab, Montreal, PQ H2L 4M1, Canada
[2] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada
[3] McGill Univ, Joint Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[4] Inst Natl Sante Publ Quebec, Direct Sante Publ Montreal Ctr, Montreal, PQ, Canada
[5] Ctr Hosp Univ Montreal, Dept Microbiol & Infectiol, Montreal, PQ H2L 4M1, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1086/420787
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the role of human papillomavirus (HPV) type 52 polymorphism in the persistence of HPV infection, which is a predictor for cervical lesions. Cervical samples obtained at 6-month intervals were tested for HPV-52 in 1055 women; 41, 12, and 58 women had persistent, transient, and unclassified HPV-52 infections, respectively. HPV-52 isolates were analyzed by polymerase chain-reaction sequencing of the long control region (LCR), E6, and E7 genes. Although age (odds ratio [OR], 0.90 [95% confidence interval {CI}, 0.81-0.99]), nonprototypic LCR (OR, 9.26 [95% CI, 2.1-41.7]), and E6 variant (OR, 7.04 [ 95% CI, 1.4-37]) were associated, in univariate analysis, with the persistence of HPV-52 infection, a nonprototypic LCR variant was the only independent predictor of it (OR, 14.1 [ 95% CI, 1.1-200]). In the latter variants, the loss of a binding site for a repressor of HPV expression was associated with the persistence of HPV infection (OR, 7.25 [ 95% CI, 1.67-31.25]).
引用
收藏
页码:46 / 52
页数:7
相关论文
共 31 条
  • [1] Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women
    Ahdieh, L
    Klein, RS
    Burk, R
    Cu-Uvin, S
    Schuman, P
    Duerr, A
    Safaeian, M
    Astemborski, J
    Daniel, R
    Shah, K
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (06) : 682 - 690
  • [2] Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative women
    Aho, J
    Hankins, C
    Tremblay, C
    Lang, F
    Forest, P
    Pourreaux, K
    Rouah, F
    Coutlée, F
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (10) : 1517 - 1527
  • [3] Overexpression of C/EBPβ represses human papillomavirus type 18 upstream regulatory region activity in HeLa cells by interfering with the binding of TATA-binding protein
    Bauknecht, T
    Shi, Y
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (03) : 2113 - 2124
  • [4] The causal relation between human papillomavirus and cervical cancer
    Bosch, FX
    Lorincz, A
    Muñoz, N
    Meijer, CJLM
    Shah, KV
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) : 244 - 265
  • [5] Chan PKS, 2002, J NATL CANCER I, V94, P1249, DOI 10.1093/jnci/94.16.1249
  • [6] Coutlee F, 1997, J MED VIROL, V51, P42, DOI 10.1002/(SICI)1096-9071(199701)51:1<42::AID-JMV7>3.0.CO
  • [7] 2-S
  • [8] Coutlée F, 1999, J CLIN MICROBIOL, V37, P1852
  • [9] Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant
    Da Costa, MM
    Hogeboom, CJ
    Holly, EA
    Palefsky, JM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (09) : 1229 - 1237
  • [10] Persistent human papillomavirus infection and cervical neoplasia
    Ferenczy, A
    Franco, E
    [J]. LANCET ONCOLOGY, 2002, 3 (01) : 11 - 16